Von Wiltman
Associate Director - Technical Operations Apertura Gene Therapy
Von Wiltman is Associate Director of Technical Operations at Apertura Gene Therapy, where he leads process development, manufacturing, and analytics for AAV programs. He brings nearly a decade of CMC and commercialization experience, previously consulting for AveXis (now Novartis Gene Therapies) and Jaguar Gene Therapy; he holds a B.S. in Chemical Engineering from Purdue University.
Seminars
Thursday 26th February 2026
Manufacturing & QC Considerations for TfR1-Targeted AAV Capsids: Balancing Innovation with Process Robustness
9:00 am
- Identifying key bottlenecks in purification and how adjustments in chromatography and filtration improve recovery and yield
- Evaluating the role of advanced analytical methods in confirming identity and consistency
- Sharing lessons on establishing platform QC methods that remain predictive and reproducible when applied to engineered capsids
